CHWY vs EYPT · P/E 45, rev $12.60B vs rev $1.2M
Chewy Inc (CHWY) versus Eyepoint Pharmaceuticals Inc (EYPT) — a side-by-side from cached financials, not a winner call.
Chewy Inc (CHWY) is a internet retail company listed on US.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
Latest reported CHWY revenue for 2026-02-01 was $12.60B. Net income was $222.8M. Revenue was up 6.2% from 2025-02-02 to 2026-02-01. CHWY currently screens at market cap $16.92B and trailing P/E 45.0.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
CHWY currently screens at market cap $16.92B and trailing P/E 45.0. EYPT currently screens at market cap $1.10B.
Not investment advice. Open the CHWY and EYPT stock pages for the full models.
Not investment advice.